Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA
View original at globenewswire.comBuffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA Dublin, Dec…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
Around 60 buffer manufacturing systems are currently available in the market for stabilizing drug components in biopharmaceuticals; notably, most of these buffer systems are offered by players based in the US
80% confidenceThe small molecules segment is likely to capture the maximum share (~75%) due to the extensive therapeutic potential of small molecules and the rising occurrence of chronic illnesses
80% confidenceThe liquid formulations segment is likely to capture the maximum share (~70%) due to liquid buffers providing consistency between batches and minimizing the chance of human mistakes
80% confidenceThe commercial scale segment is likely to capture the maximum share (~85%) and this trend is likely to remain the same in the coming years
80% confidenceThe buffer preparation market size is currently valued at USD 8.58 billion and is projected to reach 17.96 billion by 2035, growing at a CAGR of 7.8% during the forecast period
80% confidenceMore than 70 companies are offering buffer manufacturing services for different packaging formats; close to 55% of the buffer manufacturing service providers are based in North America
80% confidence86% of the buffer manufacturing systems are fabricated using stainless steel; 95% of the buffer systems work automatically with various controls for pH, conductivity, temperature and pressure
80% confidenceThe market in Asia-Pacific is likely to grow at a high CAGR (8%), during the forecast period
80% confidenceClose to 20% of the total partnership deals have been signed in the last two years, showing growing stakeholder interest in buffer manufacturing
80% confidenceThe cell and gene therapies segment will grow at a significantly higher CAGR (19.5%) throughout the forecast period
80% confidenceThe reusable buffer mixing / preparation equipment market segment is likely to capture the majority share (~80%) in the overall market in the current year and is likely to grow at a relatively faster rate during the forecast period
80% confidenceOver 60% of the firms engaged in this domain manufacture custom buffers; most of these buffers have been formulated as liquid bottles
80% confidenceNorth America is likely to capture the majority share (~40%) in the overall market currently, and this trend is unlikely to change in the future
80% confidenceThe antibodies segment is likely to capture the maximum share (~55%) of the overall market
80% confidenceThe bottles segment captures the majority share (~40%) in the overall market in the current year and is likely to dominate the market in the future
80% confidence
